Evidence map›Paper›PMID 40609793›Full record

ArticleThe Journal of biological chemistry2025

GAPDH heme delivery to Indoleamine 2,3-dioxygenase 1 involves their complex formation and complementary charge pairing at the protein-protein interface.

Pranjal Biswas, Yue Dai, Dhanya T Jayaram, Priya Das Sinha, Saurav Misra, Jesus Tejero, Belinda Willard, Dennis J Stuehr

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Key roles of GAPDH, Hsp90, and NO in heme trafficking.Journal of inorganic biochemistry · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Pranjal BiswasDepartment of Inflammation and Immunity, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Yue DaiDepartment of Inflammation and Immunity, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Dhanya T JayaramDepartment of Inflammation and Immunity, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Priya Das SinhaDepartment of Inflammation and Immunity, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Saurav MisraDepartment of Biochemistry and Molecular Biophysics, Kansas State University, Manhattan, Kansas, USA.
Jesus TejeroHeart, Lung, Blood and Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, USA; Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Belinda WillardProteomics and Metabolomics Core, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Dennis J StuehrDepartment of Inflammation and Immunity, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University School of Medicine, Cleveland, Ohio, USA. Electronic address: stuehrd@ccf.org.

Funding

Antidote for inhaled CO poisoning based on mutationally engineered neuroglobinR01HL125886 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Mark T Gladwin, Jesus Tejero Bravo · 2015 to 2026
$7.9M
Defining a pathway for mitochondrial heme traffickingR01GM148664 · NIGMS · CLEVELAND CLINIC LERNER COM-CWRU · PI DENNIS J STUEHR · 2023 to 2026
$2.1M
Coordinate control of hemeprotein maturation and function by cell chaperones, heme, and nitric oxideR01GM130624 · NIGMS · CLEVELAND CLINIC LERNER COM-CWRU · PI STUEHR, DENNIS J · 2019 to 2022
$1.9M
High-End Instrumentation (HEI) Grant Program (S10)S10OD023436 · OD · CLEVELAND CLINIC LERNER COM-CWRU · PI WILLARD, BELINDA BELLE · 2017 to 2017
$873k
Quadrupole Time-of-Flight LC-MSS10OD030398 · OD · CLEVELAND CLINIC LERNER COM-CWRU · PI WILLARD, BELINDA BELLE · 2021 to 2021
$530k
NHLBI NIH HHS R01 HL125886NIGMS NIH HHS R01 GM130624NIGMS NIH HHS R01 GM148664NIH HHS S10 OD023436NIH HHS S10 OD030398
6 · The paper itself

Abstract

In eukaryotes, the last steps of heme biosynthesis occur in mitochondria and so heme must be transported to reach many heme-dependent proteins that mature and function outside this organelle. Although the enzyme glyceraldehyde 3-phosphate dehydrogenase (GAPDH) has emerged as a key intracellular heme chaperone, how it performs heme deliveries to its numerous clients is poorly understood. It is unknown if handoffs of the GAPDH-bound heme require that it make direct contact with its clients or instead involve GAPDH passing its heme to middlemen proteins to execute the final heme transfers. To address this question, we studied GAPDH heme transfer to the client protein indoleamine 2,3-dioxygenase 1 (IDO1), whose enzyme activity is heme-dependent and regulates mammalian immune responses and cancer progression. A chemical crosslinking-mass spectrometry approach identified two Lys residues that formed an inter-protein crosslink across a previously uncharacterized GAPDH-IDO1 interface. This guided our building a model of the GAPDH-IDO1 complex so we could interrogate by point mutagenesis the role of the GAPDH-IDO1 contact in enabling delivery of GAPDH heme to IDO1. We characterized behaviors of the GAPDH and IDO1 variants in their purified form and when they were expressed in the HEK293T human cell line. This revealed GAPDH heme transfer to IDO1 in cells requires that they make a direct contact which relies on a specific Lys-Asp charge pairing interaction forming across the complex interface. These findings illuminate a key step in the maturation of functional IDO1 and improve our understanding of how GAPDH may perform its heme trafficking function in mammals.

Indexed as

Glyceraldehyde-3-Phosphate DehydrogenasesHemeIndoleamine-Pyrrole 2,3,-DioxygenaseGlyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating)HEK293 CellsHumansProtein BindingGAPDH protein, humanGlyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating)Glyceraldehyde-3-Phosphate DehydrogenasesHemeIDO1 protein, humanIndoleamine-Pyrrole 2,3,-DioxygenaseGAPDHheme insertionIDO1mass spectrometryprotein-protein interaction

Identifiers

PMID40609793
PMCPMC12329532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.